Intercure Ltd.
INCR · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Cohen Amos: Form 4
Insider disclosure · Filed · Report period 09 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q4 2024
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001857030 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- INCR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 85 Medinat Ha Yehudim Street, Herzliya, Israel, 4676670
- Incorporated in
- Israel
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields